XM does not provide services to residents of the United States of America.
C
C

Cigna

News

U.S. Broadcom, Crescent Energy, Gulfport Energy

U.S. RESEARCH ROUNDUP-Broadcom, Crescent Energy, Gulfport Energy March 8 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Broadcom, Crescent Energy Co and Gulfport Energy on Friday. HIGHLIGHTS * Broadcom Inc AVGO.O : Bernstein raises target price to $1600 from $1250 * Carvana Co CVNA.N : RBC raises to sector perform from underperform * Crescent Energy Co CRGY.N : Gerdes Energy Research raises to buy from neutral * Gul
A
B
C
C
C
D
K
M
S
A
T
A

UnitedHealth hack clouds outlook for insurers' medical costs

UnitedHealth hack clouds outlook for insurers' medical costs By Pratik Jain March 7 (Reuters) - The hack at UnitedHealth's UNH.N tech unit has led to uncertainty around when high medical costs for health insurers will subside as the cyberattack leads to prolonged delays processing insurance claims, Wall Street analysts said. While UnitedHealth said most of its pharmacy services operations, which were also taken down in the Feb.
C

Teladoc rises on expanding obesity drugs program

BUZZ-Teladoc rises on expanding obesity drugs program ** Shares of Shares of virtual healthcare provider Teladoc Health Inc TDOC.N rise 2.4% to $14.94 ** Co says it is expanding its obesity drugs program to help employers and health insurers manage rising demand for new weight-loss drugs ** New features will help sponsors and pharmacy benefit manag
C

Cigna to help health plans limit costs amid boom in weight-loss drugs

UPDATE 4-Cigna to help health plans limit costs amid boom in weight-loss drugs Adds spokesperson comment in paragraphs 3, 4 and 6 By Leroy Leo March 7 (Reuters) - Cigna Group CI.N said on Thursday its pharmacy benefit management unit had launched a program aiming to cap annual cost increases for health insurance providers and employers from new weight-loss drugs at 15%, as demand for the treatments soars.
C

Cigna launches program to help clients manage rising costs due to weight loss drug boom

Cigna launches program to help clients manage rising costs due to weight loss drug boom March 7 (Reuters) - Cigna CI.N on Thursday announced its unit is launching a financial guarantee program to help companies and other clients manage the rising drugs expenses associated with using GLP-1 weight loss and diabetes drugs. Reporting by Leroy Leo in Be
C

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.